Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $4.56M | $0.71 | $32.67 | 4,527.05% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $18.94M | $0.37 | $10.00 | 2,617.39% | Strong Buy | 2 | N/A | N/A | -35,899.88% | -513.21% | |||
| IMA | IMAGENEBIO INC | $91.30M | $8.17 | $153.00 | 1,773.85% | Buy | 2 | N/A | N/A | -58.47% | -50.82% | |||
| CANF | CAN-FITE BIOPHARMA LTD | $4.40M | $0.37 | $6.75 | 1,724.32% | Strong Buy | 2 | 719.66% | N/A | N/A | N/A | |||
| ATYR | ATYR PHARMA INC | $73.78M | $0.75 | $13.50 | 1,692.83% | Buy | 4 | 596.43% | N/A | -39.65% | -29.83% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $35.65M | $1.63 | $26.67 | 1,536.01% | Buy | 3 | 327.90% | N/A | N/A | -49.30% | |||
| NRXP | NRX PHARMACEUTICALS INC | $69.96M | $2.49 | $40.33 | 1,519.80% | Strong Buy | 3 | 1,160.38% | N/A | -556.39% | 955.57% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $149.74M | $0.45 | $7.00 | 1,473.03% | Buy | 3 | 48.30% | N/A | 842.99% | 59.37% | |||
| PSTV | PLUS THERAPEUTICS INC | $70.09M | $0.51 | $7.75 | 1,419.61% | Strong Buy | 4 | 55.70% | N/A | -83.21% | -22.52% | |||
| TVRD | TVARDI THERAPEUTICS INC | $37.81M | $4.03 | $55.50 | 1,277.17% | Strong Buy | 6 | N/A | N/A | -140.10% | -100.05% | |||
| GRI | GRI BIO INC | $5.52M | $1.69 | $22.50 | 1,231.36% | Buy | 2 | N/A | N/A | -57.98% | -24.16% | |||
| ACET | ADICET BIO INC | $101.46M | $0.66 | $8.50 | 1,183.99% | Strong Buy | 2 | N/A | N/A | -59.80% | -46.46% | |||
| KRRO | KORRO BIO INC | $57.16M | $6.07 | $74.17 | 1,121.86% | Buy | 6 | -58.86% | N/A | -127.26% | -78.01% | |||
| SKYE | SKYE BIOSCIENCE INC | $41.67M | $1.30 | $15.00 | 1,053.85% | Buy | 3 | N/A | N/A | -225.05% | -178.83% | |||
| CING | CINGULATE INC | $23.58M | $3.49 | $39.50 | 1,031.81% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| LSTA | LISATA THERAPEUTICS INC | $18.70M | $2.12 | $23.50 | 1,008.49% | Strong Buy | 2 | 60.27% | N/A | -50.75% | -40.52% | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $13.99M | $1.30 | $14.00 | 976.92% | Buy | 2 | N/A | N/A | -45.75% | -39.13% | |||
| MTVA | METAVIA INC | $16.93M | $0.70 | $7.50 | 972.96% | Strong Buy | 2 | N/A | N/A | -1,786.79% | -766.15% | |||
| VNRX | VOLITIONRX LTD | $40.65M | $0.33 | $3.50 | 957.40% | Strong Buy | 3 | 249.16% | N/A | -338.14% | 1,816.06% | |||
| CYBN | CYBIN INC | $136.59M | $5.93 | $62.50 | 953.96% | Strong Buy | 2 | N/A | N/A | -22.94% | -17.59% | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $24.07M | $0.99 | $10.00 | 909.08% | Strong Buy | 2 | N/A | N/A | -133.24% | -111.24% | |||
| RNXT | RENOVORX INC | $27.49M | $0.75 | $7.50 | 900.00% | Buy | 2 | 242.73% | N/A | 124.95% | 90.07% | |||
| ZYXI | ZYNEX INC | $17.27M | $0.57 | $5.50 | 864.91% | Buy | 2 | -6.11% | N/A | -686.20% | -10.07% | |||
| MYO | MYOMO INC | $31.36M | $0.82 | $7.83 | 859.93% | Buy | 3 | 12.85% | N/A | 50.43% | 21.64% | |||
| BOLT | BOLT BIOTHERAPEUTICS INC | $8.77M | $4.57 | $43.50 | 851.86% | Strong Buy | 2 | 27.29% | N/A | -132.90% | -65.58% | |||
| MBRX | MOLECULIN BIOTECH INC | $22.10M | $0.43 | $4.00 | 821.66% | Buy | 2 | N/A | N/A | N/A | -1,076.69% | |||
| AVXL | ANAVEX LIFE SCIENCES CORP | $313.08M | $3.65 | $33.00 | 805.35% | Strong Buy | 2 | N/A | N/A | 1,057.61% | 939.14% | |||
| SLN | SILENCE THERAPEUTICS PLC | $322.29M | $6.83 | $61.67 | 802.88% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| TIL | INSTIL BIO INC | $97.80M | $14.42 | $125.00 | 766.85% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| CTSO | CYTOSORBENTS CORP | $41.45M | $0.66 | $5.38 | 714.39% | Buy | 2 | 21.50% | N/A | N/A | N/A | |||
| NAKA | KINDLY MD INC | $4.67M | $0.61 | $5.00 | 714.33% | Strong Buy | 2 | 470.58% | N/A | -1.73% | -1.57% | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $10.10M | $8.01 | $65.00 | 711.99% | Buy | 2 | N/A | N/A | -80.52% | -67.15% | |||
| IMUX | IMMUNIC INC | $93.70M | $0.78 | $6.00 | 670.22% | Strong Buy | 4 | N/A | N/A | 413.70% | 106.71% | |||
| IFRX | INFLARX NV | $91.46M | $1.35 | $10.33 | 665.41% | Strong Buy | 3 | 215.41% | N/A | -75.48% | -52.55% | |||
| ATOS | ATOSSA THERAPEUTICS INC | $103.34M | $0.80 | $5.88 | 634.38% | Buy | 2 | N/A | N/A | -86.01% | -73.81% | |||
| HUMA | HUMACYTE INC | $230.34M | $1.23 | $8.67 | 604.63% | Strong Buy | 6 | 285.88% | N/A | -15,117.30% | 784.87% | |||
| JSPR | JASPER THERAPEUTICS INC | $47.01M | $1.68 | $11.43 | 580.30% | Buy | 7 | N/A | N/A | -761.65% | -153.35% | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $57.76M | $0.50 | $3.33 | 563.94% | Strong Buy | 6 | N/A | N/A | -180.56% | -57.32% | |||
| CABA | CABALETTA BIO INC | $222.37M | $2.31 | $14.60 | 532.03% | Strong Buy | 5 | N/A | N/A | -84.72% | -62.27% | |||
| BMEA | BIOMEA FUSION INC | $90.50M | $1.28 | $8.00 | 525.00% | Strong Buy | 5 | N/A | N/A | -537.15% | -152.02% | |||
| AMTX | AEMETIS INC | $125.89M | $1.92 | $12.00 | 525.00% | Strong Buy | 2 | 62.87% | N/A | -56.82% | 71.84% | |||
| BNGO | BIONANO GENOMICS INC | $15.47M | $1.52 | $9.50 | 525.00% | Strong Buy | 2 | 22.63% | N/A | -10.63% | -6.70% | |||
| NKTX | NKARTA INC | $132.83M | $1.87 | $11.67 | 523.90% | Strong Buy | 3 | N/A | N/A | -29.37% | -23.23% | |||
| AKTX | AKARI THERAPEUTICS PLC | $37.81M | $0.53 | $3.30 | 523.82% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| CATX | PERSPECTIVE THERAPEUTICS INC | $154.62M | $2.08 | $12.60 | 505.77% | Strong Buy | 5 | -20.15% | N/A | -36.10% | -29.66% | |||
| SNTI | SENTI BIOSCIENCES INC | $42.33M | $1.61 | $9.67 | 500.43% | Strong Buy | 3 | N/A | N/A | -662.08% | -102.05% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.